| Literature DB >> 28504011 |
André Mansinho1,2, Valentina Boni2, María de Miguel2, Emiliano Calvo2.
Abstract
Keywords: Precision oncology; clinical drug development; healthcare sustainability; immunotherapy; targeted therapy
Mesh：
Substances：
Year: 2017 PMID： 28504011 DOI： 10.1080/14737140.2017.1331131
Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN： 1473-7140 Impact factor: 4.512